No phaseActive, not recruiting

Impact of a Novel Brain Longevity Supplement Containing the Postbiotic Urolithin A (Mitopure) on Cognitive Function and Related Health Outcomes (CLARITY)

Radicle Clarity™ 25_RAM: A Randomized, Double-Blind, Placebo-Controlled Direct-to-Consumer Study Assessing the Impact of Health and Wellness Products on Cognitive Function and Related Health Outcomes

Sponsor
Amazentis SA (Industry)
Enrolment
650 enrolled
Conditions
Aging; Cognitive Decline; Brain Fog; Cognitive Function
Interventions
Active Product; Placebo Product
Ages
adults, older adults
Registry
NCT07060898

From the registry

This is a parallel group, randomized, double-blind, placebo-controlled clinical study assessing the safety and effects of a novel nutritional product on self-reported cognitive function and health in adults that reside in the USA. Participants will take their assigned study product (active or placebo) for 8 weeks and answer validated electronic surveys assessing cognitive function delivered to them through a text message (SMS) link or through email.

Primary outcomes

  • Cognitive function
Full record on ClinicalTrials.gov